BCL2-Antagonist/killer 1 (BAK1) Peptide
BAK1
Reactivity: Human
Host: Synthetic
BP
-
- Target See all BAK1 products
- BAK1 (BCL2-Antagonist/killer 1 (BAK1))
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP)
- Characteristics
- The peptide is used to block Anti-BAK Antibody reactivity.
-
BCL2-Antagonist/killer 1 (BAK1) peptide
BAK1 Reactivity: Human, Mouse, Pig, Rat Host: Synthetic BP, Imm
-
- Application Notes
- Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4 °C for overnight or at room temperature for 2 hours.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Storage
- -20 °C
- Storage Comment
- Shipped at 4°C. Store at -20°C for one year.
- Expiry Date
- 12 months
-
- Target
- BAK1 (BCL2-Antagonist/killer 1 (BAK1))
- Synonyms
- BAK Peptide, BAK-LIKE Peptide, BCL2L7 Peptide, CDN1 Peptide, Bak Peptide, N-BAK1 Peptide, N-Bak Peptide, Bak1 Peptide, bak Peptide, bak1 Peptide, BCL2 antagonist/killer 1 Peptide, BCL2-antagonist/killer 1 Peptide, BCL2 antagonist/killer 1 L homeolog Peptide, BAK1 Peptide, Bak1 Peptide, bak1.L Peptide
- Background
- BAK, BCL2L7, CDN1, Bcl-2 homologous antagonist/killer, Apoptosis regulator BAK, Bcl-2-like protein 7, Bcl2-L-7
- Gene ID
- 578
- UniProt
- Q16611
-
You are here:
